Abstract

Background: Parkinson disease (PD) is a neurodegenerative disease characterized by motor and nonmotor dysfunctions, which include sleep disturbances. Rapid eye movement (REM) sleep is associated with numerous physiologic changes such as memory consolidation. Compelling evidence suggests that nitric oxide (NO) is crucial to both sleep regulation and memory consolidation. In our study, we explored changes in biologic molecules during various sleep stages and the effects of sleep on memory consolidation in PD. Methods: Ten PD patients and 14 volunteers without PD participated in our study. The gene expression of inducible NO synthase (iNOS) in all sleep stages was measured using realtime polymerase chain reaction (PCR) based on polysomnography (PSG)-guided peripheral blood sampling. In addition, the efficiency of memory consolidation during the sleep of the participants was measured using the Wechsler Memory Scale, third edition (WMS-III). Results: The iNOS expression increased in all sleep stages among the PD patients compared to the control participants, in whom iNOS expression decreased during REM sleep. Regarding memory consolidation, the performance of the controls in logic memory and the patients in visual reproduction tasks improved after sleep. Conclusions: The iNOS synthase expression was different from control participants among PD patients, and the expression was dissimilar in various sleep stages. Sleep might enhance memory consolidation and there are different memory consolidation profiles between PD and control participants demonstrating distinct memory consolidation profiles.

Original languageEnglish
Pages (from-to)116-120
Number of pages5
JournalSleep Medicine
Volume15
Issue number1
DOIs
Publication statusPublished - Jan 2014

Fingerprint

Sleep Stages
Nitric Oxide Synthase Type II
Parkinson Disease
Sleep
Nitric Oxide Synthase
REM Sleep
Wechsler Scales
Memory Consolidation
Polysomnography
Neurodegenerative Diseases
Reproduction
Volunteers
Nitric Oxide
Efficiency
Gene Expression
Polymerase Chain Reaction

Keywords

  • INOS
  • Memory consolidation
  • NO
  • Parkinson disease
  • Polysomnography
  • REM sleep

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{410f1d41abaa4077b9e9c54b59076550,
title = "Memory consolidation and inducible nitric oxide synthase expression during different sleep stages in Parkinson disease",
abstract = "Background: Parkinson disease (PD) is a neurodegenerative disease characterized by motor and nonmotor dysfunctions, which include sleep disturbances. Rapid eye movement (REM) sleep is associated with numerous physiologic changes such as memory consolidation. Compelling evidence suggests that nitric oxide (NO) is crucial to both sleep regulation and memory consolidation. In our study, we explored changes in biologic molecules during various sleep stages and the effects of sleep on memory consolidation in PD. Methods: Ten PD patients and 14 volunteers without PD participated in our study. The gene expression of inducible NO synthase (iNOS) in all sleep stages was measured using realtime polymerase chain reaction (PCR) based on polysomnography (PSG)-guided peripheral blood sampling. In addition, the efficiency of memory consolidation during the sleep of the participants was measured using the Wechsler Memory Scale, third edition (WMS-III). Results: The iNOS expression increased in all sleep stages among the PD patients compared to the control participants, in whom iNOS expression decreased during REM sleep. Regarding memory consolidation, the performance of the controls in logic memory and the patients in visual reproduction tasks improved after sleep. Conclusions: The iNOS synthase expression was different from control participants among PD patients, and the expression was dissimilar in various sleep stages. Sleep might enhance memory consolidation and there are different memory consolidation profiles between PD and control participants demonstrating distinct memory consolidation profiles.",
keywords = "INOS, Memory consolidation, NO, Parkinson disease, Polysomnography, REM sleep",
author = "Dean Wu and Tseng, {Ing Jy} and Rey-Yue Yuan and Hsieh, {Chia Yu} and Chaur-Jong Hu",
year = "2014",
month = "1",
doi = "10.1016/j.sleep.2013.09.016",
language = "English",
volume = "15",
pages = "116--120",
journal = "Sleep Medicine",
issn = "1389-9457",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Memory consolidation and inducible nitric oxide synthase expression during different sleep stages in Parkinson disease

AU - Wu, Dean

AU - Tseng, Ing Jy

AU - Yuan, Rey-Yue

AU - Hsieh, Chia Yu

AU - Hu, Chaur-Jong

PY - 2014/1

Y1 - 2014/1

N2 - Background: Parkinson disease (PD) is a neurodegenerative disease characterized by motor and nonmotor dysfunctions, which include sleep disturbances. Rapid eye movement (REM) sleep is associated with numerous physiologic changes such as memory consolidation. Compelling evidence suggests that nitric oxide (NO) is crucial to both sleep regulation and memory consolidation. In our study, we explored changes in biologic molecules during various sleep stages and the effects of sleep on memory consolidation in PD. Methods: Ten PD patients and 14 volunteers without PD participated in our study. The gene expression of inducible NO synthase (iNOS) in all sleep stages was measured using realtime polymerase chain reaction (PCR) based on polysomnography (PSG)-guided peripheral blood sampling. In addition, the efficiency of memory consolidation during the sleep of the participants was measured using the Wechsler Memory Scale, third edition (WMS-III). Results: The iNOS expression increased in all sleep stages among the PD patients compared to the control participants, in whom iNOS expression decreased during REM sleep. Regarding memory consolidation, the performance of the controls in logic memory and the patients in visual reproduction tasks improved after sleep. Conclusions: The iNOS synthase expression was different from control participants among PD patients, and the expression was dissimilar in various sleep stages. Sleep might enhance memory consolidation and there are different memory consolidation profiles between PD and control participants demonstrating distinct memory consolidation profiles.

AB - Background: Parkinson disease (PD) is a neurodegenerative disease characterized by motor and nonmotor dysfunctions, which include sleep disturbances. Rapid eye movement (REM) sleep is associated with numerous physiologic changes such as memory consolidation. Compelling evidence suggests that nitric oxide (NO) is crucial to both sleep regulation and memory consolidation. In our study, we explored changes in biologic molecules during various sleep stages and the effects of sleep on memory consolidation in PD. Methods: Ten PD patients and 14 volunteers without PD participated in our study. The gene expression of inducible NO synthase (iNOS) in all sleep stages was measured using realtime polymerase chain reaction (PCR) based on polysomnography (PSG)-guided peripheral blood sampling. In addition, the efficiency of memory consolidation during the sleep of the participants was measured using the Wechsler Memory Scale, third edition (WMS-III). Results: The iNOS expression increased in all sleep stages among the PD patients compared to the control participants, in whom iNOS expression decreased during REM sleep. Regarding memory consolidation, the performance of the controls in logic memory and the patients in visual reproduction tasks improved after sleep. Conclusions: The iNOS synthase expression was different from control participants among PD patients, and the expression was dissimilar in various sleep stages. Sleep might enhance memory consolidation and there are different memory consolidation profiles between PD and control participants demonstrating distinct memory consolidation profiles.

KW - INOS

KW - Memory consolidation

KW - NO

KW - Parkinson disease

KW - Polysomnography

KW - REM sleep

UR - http://www.scopus.com/inward/record.url?scp=84891628628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891628628&partnerID=8YFLogxK

U2 - 10.1016/j.sleep.2013.09.016

DO - 10.1016/j.sleep.2013.09.016

M3 - Article

C2 - 24286896

AN - SCOPUS:84891628628

VL - 15

SP - 116

EP - 120

JO - Sleep Medicine

JF - Sleep Medicine

SN - 1389-9457

IS - 1

ER -